English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52845214    Online Users :  629
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 		 
Scope Adv. Search
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR
About TAIR

Browse By
Institution
Author
Title
Date
Statistics Chart
Institution Facts
Trend

News
2019臺灣學術機構典藏
研討會
機構典藏系統RC7版本已
發佈

Copyright
Publisher & Journal Policy
TAIR Copyright Conference Minutes

Related Links
機構典藏計畫網站
ROAR
OpenDOAR
SHERPA
OAIster
JAIRO
Ira
DSPACE
RWWR
臺大學術典藏NTU Scholars
Taiwan Academic Institutional Repository >  Browse by Author

"shih j y"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 741-790 of 1137  (23 Page(s) Totally)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-05-26T09:27:26Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Chih-Hsin Yang;Shih J.-Y;Chen K.-C;Yu C.-J;Yang T.-Y;Lin C.-P;Su W.-P;Gow C.-H;Hsu C;Chang G.-C;Yang P.-C.; CHIH-HSIN YANG; Shih J.-Y; Chen K.-C; Yu C.-J; Yang T.-Y; Lin C.-P; Su W.-P; Gow C.-H; Hsu C; Chang G.-C; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:24Z Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response Yang P.-C.;Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Kuo S.-H;Chiu Y.-H;Chang Y.-L;Chien C.-R;Gow C.-H; Gow C.-H; Chien C.-R; Chang Y.-L; Chiu Y.-H; Kuo S.-H; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:24Z MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib Bean J;Brennan C;Shih J.-Y;Riely G;Viale A;Wang L;Chitale D;Motoi N;Szoke J;Broderick S;Balak M;Chang W.-C;Yu C.-J;Gazdar A;Pass H;Rusch V;Gerald W;Huang S.-F;Yang P.-C;Miller V;Ladanyi M;Chih-Hsin Yang;Pao W.; Bean J; Brennan C; Shih J.-Y; Riely G; Viale A; Wang L; Chitale D; Motoi N; Szoke J; Broderick S; Balak M; Chang W.-C; Yu C.-J; Gazdar A; Pass H; Rusch V; Gerald W; Huang S.-F; Yang P.-C; Miller V; Ladanyi M; CHIH-HSIN YANG; Pao W.
臺大學術典藏 2020-05-26T09:27:23Z Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers Chih-Hsin Yang;Shih J.-Y;Hsu C;Yu C.-J;Lo Y;Chen J.-P; Chen J.-P; Lo Y; Yu C.-J; Hsu C; Shih J.-Y; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:27:22Z Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Shih J.-Y; Lee Y.-C; Yang P.-C.; Yang P.-C.;Lee Y.-C;Shih J.-Y;Hsu Y.-C;Chih-Hsin Yang;Chang Y.-L;Yu C.-J;Gow C.-H;Wu S.-G; Wu S.-G; Gow C.-H; Yu C.-J; Chang Y.-L; CHIH-HSIN YANG; Hsu Y.-C
臺大學術典藏 2020-05-26T09:27:22Z Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy Yang P.-C.;Pao W;Cheng A.-L;Bean J;Huang C.-L;Shun C.-T;Huang C.-J;Lin Z.-Z;Chen K.-Y;Tsai M.-C;Hu F.-C;Chang Y.-C;Shih J.-Y;Yu C.-J;Chih-Hsin Yang; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Chang Y.-C; Hu F.-C; Tsai M.-C; Chen K.-Y; Lin Z.-Z; Huang C.-J; Shun C.-T; Huang C.-L; Bean J; Cheng A.-L; Pao W; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:21Z Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Lin C.-C; Huang T.-C; Yang P.-C; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Cheng A.-L; Hu F.-C; Kuo S.-H; Hsu C; Chih-Hsin Yang;Yang P.-C;Huang T.-C;Lin C.-C;Yu C.-J;Shih J.-Y;Cheng A.-L;Hu F.-C;Kuo S.-H;Hsu C
臺大學術典藏 2020-05-26T09:27:21Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:21Z Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:19Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L; CHIH-HSIN YANG; Yeh K.-H; Hu F.-C; Chen K.-Y; Shih J.-Y; Lin Z.-Z; Yu C.-J; Cheng A.-L; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:19Z Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Gow C.-H; Chang Y.-L; Hsu Y.-C; Tsai M.-F; Wu C.-T; Yu C.-J; CHIH-HSIN YANG; Lee Y.-C; Yang P.-C; Shih J.-Y.
臺大學術典藏 2020-05-26T09:27:18Z Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors Yang P.-C.; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y; Chen J.-H; Chen K.-Y; Chen K.-Y;Chen J.-H;Shih J.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.
臺大學術典藏 2020-05-26T09:27:18Z Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer Wu J.-Y;Shih J.-Y;Chih-Hsin Yang;Chen K.-Y;Ho C.-C;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; CHIH-HSIN YANG; Chen K.-Y; Ho C.-C; Yu C.-J; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:18Z Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors Lin C.-C;Hsu H.-H;Sun C.-T;Shih J.-Y;Lin Z.-Z;Yu C.-J;Chen G.G;Hsin M.K.Y;Lam K.C;Leung L;Chih-Hsin Yang;Mok T.; Lin C.-C; Hsu H.-H; Sun C.-T; Shih J.-Y; Lin Z.-Z; Yu C.-J; Chen G.G; Hsin M.K.Y; Lam K.C; Leung L; CHIH-HSIN YANG; Mok T.
臺大學術典藏 2020-05-26T09:27:18Z Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer Lee J.-H;Yu C.-J;Chen K.-Y;Shih J.-Y;Lin Y.-L;Chih-Hsin Yang; Lee J.-H; Yu C.-J; Chen K.-Y; Shih J.-Y; Lin Y.-L; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:27:17Z Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma Yen R.-F; Cheng M.-F; Hsu Y.-C; Wei P.-F; Tsai Y.-J; Tsai M.-F; Shih J.-Y; CHIH-HSIN YANG; Yang P.-C.; Huang C.-T;Yen R.-F;Cheng M.-F;Hsu Y.-C;Wei P.-F;Tsai Y.-J;Tsai M.-F;Shih J.-Y;Chih-Hsin Yang;Yang P.-C.; Huang C.-T
臺大學術典藏 2020-05-26T09:27:16Z Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer Shih J.-Y; Chang S.-H; Yu C.-J; Hsu Y.-C; CHIH-HSIN YANG; Wu J.-Y; Wu J.-Y;Chih-Hsin Yang;Hsu Y.-C;Yu C.-J;Chang S.-H;Shih J.-Y;Yang P.-C.; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:16Z Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer Wu J.-Y;Yu C.-J;Shih J.-Y;Chih-Hsin Yang;Yang P.-C.; Wu J.-Y; Yu C.-J; Shih J.-Y; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:15Z Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach Salto-Tellez M;Tsao M.-S;Shih J.-Y;Thongprasert S;Lu S;Chang G.-C;Au J.S.-K;Chou T.-Y;Lee J.-S;Shi Y.-K;Radzi A;Kang J.-H;Kim S.-W;Tan S.-Y;Chih-Hsin Yang; Salto-Tellez M; Tsao M.-S; Shih J.-Y; Thongprasert S; Lu S; Chang G.-C; Au J.S.-K; Chou T.-Y; Lee J.-S; Shi Y.-K; Radzi A; Kang J.-H; Kim S.-W; Tan S.-Y; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:27:13Z Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations Wu J.-Y;Wu S.-G;Chih-Hsin Yang;Chang Y.-L;Chang Y.-C;Hsu Y.-C;Shih J.-Y;Yang P.-C.; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Chang Y.-L; Chang Y.-C; Hsu Y.-C; Shih J.-Y; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:12Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations CHIH-HSIN YANG; Yu C.-J; Lee J.-H; Hsu Y.-C; Chang Y.-L; Shih J.-Y; Yang P.-C.; Wu S.-G;Chih-Hsin Yang;Yu C.-J;Lee J.-H;Hsu Y.-C;Chang Y.-L;Shih J.-Y;Yang P.-C.; Wu S.-G
臺大學術典藏 2020-05-26T09:27:12Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y;Shih J.-Y;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:12Z Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer Wu J.-Y;Yu C.-J;Chang Y.-C;Chih-Hsin Yang;Shih J.-Y;Yang P.-C.; Wu J.-Y; Yu C.-J; Chang Y.-C; CHIH-HSIN YANG; Shih J.-Y; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:11Z Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed Chen C.-Y;Chang Y.-L;Shih J.-Y;Lin J.-W;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Chen C.-Y; Chang Y.-L; Shih J.-Y; Lin J.-W; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:10Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Yang P.-C.;Chih-Hsin Yang;Yu C.-J;Tsai M.-F;Chen Y.-H;Shih J.-Y;Chang Y.-L;Kuo Y.-W;Wu S.-G; Wu S.-G; Kuo Y.-W; Chang Y.-L; Shih J.-Y; Chen Y.-H; Tsai M.-F; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:09Z Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum Yu C.-J.;Chen Y.-M;Chih-Hsin Yang;Cheng Y.-K;Chang G.-C;Shih J.-Y;Liao W.-Y; Liao W.-Y; Shih J.-Y; Chang G.-C; Cheng Y.-K; CHIH-HSIN YANG; Chen Y.-M; Yu C.-J.
臺大學術典藏 2020-05-26T09:27:08Z Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer Li K.-C; Kuo M.-L; CHIH-HSIN YANG; Chan W.-K; Ho B.-C; Chang G.-C; Shih J.-Y; Yu S.-L; Yang P.-C.; Yang P.-C.;Yu S.-L;Shih J.-Y;Chang G.-C;Ho B.-C;Chan W.-K;Chih-Hsin Yang;Kuo M.-L;Li K.-C;Chen H.-Y;Su K.-Y; Su K.-Y; Chen H.-Y
臺大學術典藏 2020-05-26T09:27:07Z Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR Yang P.-C.;Shih J.-Y;Wei P.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Wu S.-G;Chung K.-P; Chung K.-P; Wu S.-G; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:07Z Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors Yang P.-C.;Yu C.-J;Chih-Hsin Yang;Ho C.-C;Shih J.-Y;Chen K.-Y;Hsu C.-L; Hsu C.-L; Chen K.-Y; Shih J.-Y; Ho C.-C; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏 2020-05-26T09:27:07Z Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial Miller V.A.;Yang P.-C;Lorence R.M;Cong X.J;Shahidi M;Dudek A.Z;Sequist L.V;Ho C.-L;Chang G.-C;Yu C.-J;Ou S.H.I;Tsai C.-M;Hsia T.-C;Su W.-C;Shih J.-Y;Chih-Hsin Yang; CHIH-HSIN YANG; Shih J.-Y; Su W.-C; Hsia T.-C; Tsai C.-M; Ou S.H.I; Yu C.-J; Chang G.-C; Ho C.-L; Sequist L.V; Dudek A.Z; Shahidi M; Cong X.J; Lorence R.M; Yang P.-C; Miller V.A.
臺大學術典藏 2020-05-26T09:27:04Z ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors Huang C.-P;Tsai M.-F;Chang T.-H;Tang W.-C;Chen S.-Y;Lai H.-H;Lin T.-Y;Chih-Hsin Yang;Yang P.-C;Shih J.-Y;Lin S.-B.; Huang C.-P; Tsai M.-F; Chang T.-H; Tang W.-C; Chen S.-Y; Lai H.-H; Lin T.-Y; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y; Lin S.-B.
臺大學術典藏 2020-05-26T09:27:03Z Survival of lung adenocarcinoma patients with malignant pleural effusion Wu S.-G;Yu C.-J;Tsai M.-F;Liao W.-Y;Chih-Hsin Yang;Jan I.-S;Yang P.-C;Shih J.-Y.; Wu S.-G; Yu C.-J; Tsai M.-F; Liao W.-Y; CHIH-HSIN YANG; Jan I.-S; Yang P.-C; Shih J.-Y.
臺大學術典藏 2020-05-26T09:27:02Z Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer Liao W.-Y;Chen J.-H;Wu M;Shih J.-Y;Chen K.-Y;Ho C.-C;Chih-Hsin Yang;Yu C.-J.; Liao W.-Y; Chen J.-H; Wu M; Shih J.-Y; Chen K.-Y; Ho C.-C; CHIH-HSIN YANG; Yu C.-J.
臺大學術典藏 2020-05-26T09:27:00Z Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer Lee J.-H; Lin Y.-L; Hsu W.-H; Chen H.-Y; Chang Y.-C; Yu C.-J; Shih J.-Y; Lin C.-C; Chen K.-Y; Ho C.-C; Laio W.-Y; Yang P.-C; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:27:00Z Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy Tsai T.-H;Yang C.-Y;Ho C.-C;Liao W.-Y;Jan I.-S;Chen K.-Y;Wang J.-Y;Ruan S.-Y;Yu C.-J;Chih-Hsin Yang;Yang P.-C;Shih J.-Y.; Tsai T.-H; Yang C.-Y; Ho C.-C; Liao W.-Y; Jan I.-S; Chen K.-Y; Wang J.-Y; Ruan S.-Y; Yu C.-J; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:59Z Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations Chen Y.-F;Hsieh M.-S;Wu S.-G;Chang Y.-L;Shih J.-Y;Liu Y.-N;Tsai M.-F;Tsai T.-H;Yu C.-J;Chih-Hsin Yang;Yang P.-C.; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Shih J.-Y; Liu Y.-N; Tsai M.-F; Tsai T.-H; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏 2020-05-26T09:26:57Z Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer Yang P.-C.; Shih J.-Y; Wu S.-G; Yu C.-J; CHIH-HSIN YANG; Wang Y.-F; Lin Y.-T; Lin Y.-T;Wang Y.-F;Chih-Hsin Yang;Yu C.-J;Wu S.-G;Shih J.-Y;Yang P.-C.
臺大學術典藏 2020-05-26T09:26:56Z IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer Shih J.-Y.;Chih-Hsin Yang;Yu S.-L;Chen H.-Y;Tsai T.-H;Wu S.-G;Tsai M.-F;Chang T.-H;Liu Y.-N; Liu Y.-N; Chang T.-H; Tsai M.-F; Wu S.-G; Tsai T.-H; Chen H.-Y; Yu S.-L; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:55Z Treating patients with ALK-positive non-small cell lung cancer: Latest evidence and management strategy Chih-Hsin Yang;Shih J.Y;Lin C.C;Liao B.C; Liao B.C; Lin C.C; Shih J.Y; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:26:55Z Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis Yang P.-C.;Yu C.-J;Chih-Hsin Yang;Shih J.-Y;Chen K.-Y;Chen J.-H;Hsu C.-L; Hsu C.-L; Chen J.-H; Chen K.-Y; Shih J.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏 2020-05-26T09:26:53Z Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Hsieh M.-S;Wu S.-G;Tsai T.-H; Tsai T.-H; Wu S.-G; Hsieh M.-S; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:52Z Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Chang C.-H;Chen Y.-F;Lin C.-C;Lee J.-H;Liao B.-C; Liao B.-C; Lee J.-H; Lin C.-C; Chen Y.-F; Chang C.-H; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:26:52Z Rapid Response to Sunitinib in a Patient with Lung Adenocarcinoma Harboring KIF5B-RET Fusion Gene CHIH-HSIN YANG; Shih J.-Y; Wu H; Chih-Hsin Yang;Shih J.-Y;Wu H
臺大學術典藏 2020-05-26T09:26:51Z The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases Kuo S.-H.;Cheng A.-L;Lan K.-H;Lin Z.-Z;Shih J.-Y;Chen Y.-H;Hsu F.-M;Chih-Hsin Yang;Chiang Y; Chiang Y; CHIH-HSIN YANG; Hsu F.-M; Chen Y.-H; Shih J.-Y; Lin Z.-Z; Lan K.-H; Cheng A.-L; Kuo S.-H.
臺大學術典藏 2020-05-26T09:26:50Z Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations Shih J.-Y.;Yang P.-C;Chih-Hsin Yang;Yu C.-J;Chang Y.-L;Wu S.-G;Hsieh M.-S;Chen Y.-F; Chen Y.-F; Hsieh M.-S; Wu S.-G; Chang Y.-L; Yu C.-J; CHIH-HSIN YANG; Yang P.-C; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:48Z The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients Shih J.-Y.;Wen Y.-F;Chih-Hsin Yang;Yang P.-C;Yu C.-J;Chang Y.-L;Tsai M.-F;Liu Y.-N;Wu S-G; Wu S-G; Liu Y.-N; Tsai M.-F; Chang Y.-L; Yu C.-J; Yang P.-C; CHIH-HSIN YANG; Wen Y.-F; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:47Z Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis Yang P.-C.;Rosell R;Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Yu K.-L;Liao W.-Y;Su K.-Y;Ruan S.-Y;Molina-Vila M.A;Chen L.-Y; Chen L.-Y; Molina-Vila M.A; Ruan S.-Y; Su K.-Y; Liao W.-Y; Yu K.-L; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG; Rosell R; Yang P.-C.
臺大學術典藏 2020-05-26T09:26:47Z 151P: Outcomes of research biopsies in clinical trials of EGFR mutation-positive NSCLC patients pretreated with EGFR-TKIs Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Ho C.-C;Lee Y.-F;Lin S.-Y;Lin C.-C;Bai Y.-Y;Liao B.-C; Liao B.-C; Bai Y.-Y; Lin C.-C; Lin S.-Y; Lee Y.-F; Ho C.-C; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:26:44Z Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non?�Small-Cell Lung Cancer: Analysis and Literature Review Shih J.-Y.;Chih-Hsin Yang;Yu C.-J;Lin Y.-T; Lin Y.-T; Yu C.-J; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏 2020-05-26T09:26:39Z Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib Shih J.-Y; Yu C.-J; Chih-Hsin CHIH-HSIN YANG; Lin C.-A; Liao W.-Y; Ho C.-C; Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Lin C.-A;Liao W.-Y;Ho C.-C

Showing items 741-790 of 1137  (23 Page(s) Totally)
<< < 10 11 12 13 14 15 16 17 18 19 > >>
View [10|25|50] records per page

DSpace Software Copyright © 2002-2004  MIT   &  Hewlett-Packard   /   Enhanced by   NTU Library IR team